N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine

C118H124F15N33O — CID 158755834

IUPACN-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine
SMILESC/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCCC3)n2)=NC1.C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCN(C)CC3)n2)=NC1.C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCNCC3)n2)=NC1.C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCOCC3)n2)=NC1.CN1CCCN(c2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(NC3=NCC(C4CC4)=C3)n2)CC1
InChIInChI=1S/C25H28F3N7.C24H26F3N7.C23H24F3N7.C23H23F3N6O.C23H23F3N6/c1-34-10-3-11-35(13-12-34)24-32-21(9-6-17-4-2-5-20(14-17)25(26,27)28)30-23(33-24)31-22-15-19(16-29-22)18-7-8-18;1-3-5-18-15-21(28-16-18)30-22-29-20(31-23(32-22)34-12-10-33(2)11-13-34)9-8-17-6-4-7-19(14-17)24(25,26)27;1-2-4-17-14-20(28-15-17)30-21-29-19(31-22(32-21)33-11-9-27-10-12-33)8-7-16-5-3-6-18(13-16)23(24,25)26;1-2-4-17-14-20(27-15-17)29-21-28-19(30-22(31-21)32-9-11-33-12-10-32)8-7-16-5-3-6-18(13-16)23(24,25)26;1-2-6-17-14-20(27-15-17)29-21-28-19(30-22(31-21)32-11-3-4-12-32)10-9-16-7-5-8-18(13-16)23(24,25)26/h2,4-6,9,14-15,18H,3,7-8,10-13,16H2,1H3,(H,29,30,31,32,33);3-9,14-15H,10-13,16H2,1-2H3,(H,28,29,30,31,32);2-8,13-14,27H,9-12,15H2,1H3,(H,28,29,30,31,32);2-8,13-14H,9-12,15H2,1H3,(H,27,28,29,30,31);2,5-10,13-14H,3-4,11-12,15H2,1H3,(H,27,28,29,30,31)/b9-6+;5-3+,9-8+;2*4-2+,8-7+;6-2+,10-9+
InChIKeyIOBIVSXFPZXUQG-VMRXWINHSA-N
MW2305.49 g/mol
LogP21.51
Rot. Bonds25

About N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine

N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine (PubChem CID 158755834) has the molecular formula C118H124F15N33O and a molecular weight of 2305.49 g/mol. Its IUPAC name is N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine.

Molecular Properties

Compound NameN-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine
PubChem CID158755834
Molecular FormulaC118H124F15N33O
Molecular Weight2305.49 g/mol
Exact Mass2304.04
IUPAC NameN-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine
SMILESC/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCCC3)n2)=NC1.C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCN(C)CC3)n2)=NC1.C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCNCC3)n2)=NC1.C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCOCC3)n2)=NC1.CN1CCCN(c2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(NC3=NCC(C4CC4)=C3)n2)CC1
InChIInChI=1S/C25H28F3N7.C24H26F3N7.C23H24F3N7.C23H23F3N6O.C23H23F3N6/c1-34-10-3-11-35(13-12-34)24-32-21(9-6-17-4-2-5-20(14-17)25(26,27)28)30-23(33-24)31-22-15-19(16-29-22)18-7-8-18;1-3-5-18-15-21(28-16-18)30-22-29-20(31-23(32-22)34-12-10-33(2)11-13-34)9-8-17-6-4-7-19(14-17)24(25,26)27;1-2-4-17-14-20(28-15-17)30-21-29-19(31-22(32-21)33-11-9-27-10-12-33)8-7-16-5-3-6-18(13-16)23(24,25)26;1-2-4-17-14-20(27-15-17)29-21-28-19(30-22(31-21)32-9-11-33-12-10-32)8-7-16-5-3-6-18(13-16)23(24,25)26;1-2-6-17-14-20(27-15-17)29-21-28-19(30-22(31-21)32-11-3-4-12-32)10-9-16-7-5-8-18(13-16)23(24,25)26/h2,4-6,9,14-15,18H,3,7-8,10-13,16H2,1H3,(H,29,30,31,32,33);3-9,14-15H,10-13,16H2,1-2H3,(H,28,29,30,31,32);2-8,13-14,27H,9-12,15H2,1H3,(H,28,29,30,31,32);2-8,13-14H,9-12,15H2,1H3,(H,27,28,29,30,31);2,5-10,13-14H,3-4,11-12,15H2,1H3,(H,27,28,29,30,31)/b9-6+;5-3+,9-8+;2*4-2+,8-7+;6-2+,10-9+
InChIKeyIOBIVSXFPZXUQG-VMRXWINHSA-N
XLogP21.51
TPSA359.24 Ų
H-Bond Donors6
H-Bond Acceptors34
Rotatable Bonds25
Heavy Atoms167
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002305.49
LogP ≤ 521.51
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1034

Analyze N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine?
The IUPAC name of N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine (CID 158755834) is N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine.
What is the SMILES notation for N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine?
The canonical SMILES for N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine is C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCCC3)n2)=NC1.C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCN(C)CC3)n2)=NC1.C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCNCC3)n2)=NC1.C/C=C/C1=CC(Nc2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(N3CCOCC3)n2)=NC1.CN1CCCN(c2nc(/C=C/c3cccc(C(F)(F)F)c3)nc(NC3=NCC(C4CC4)=C3)n2)CC1.
What is the InChIKey of N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine?
The InChIKey is IOBIVSXFPZXUQG-VMRXWINHSA-N. The full InChI is InChI=1S/C25H28F3N7.C24H26F3N7.C23H24F3N7.C23H23F3N6O.C23H23F3N6/c1-34-10-3-11-35(13-12-34)24-32-21(9-6-17-4-2-5-20(14-17)25(26,27)28)30-23(33-24)31-22-15-19(16-29-22)18-7-8-18;1-3-5-18-15-21(28-16-18)30-22-29-20(31-23(32-22)34-12-10-33(2)11-13-34)9-8-17-6-4-7-19(14-17)24(25,26)27;1-2-4-17-14-20(28-15-17)30-21-29-19(31-22(32-21)33-11-9-27-10-12-33)8-7-16-5-3-6-18(13-16)23(24,25)26;1-2-4-17-14-20(27-15-17)29-21-28-19(30-22(31-21)32-9-11-33-12-10-32)8-7-16-5-3-6-18(13-16)23(24,25)26;1-2-6-17-14-20(27-15-17)29-21-28-19(30-22(31-21)32-11-3-4-12-32)10-9-16-7-5-8-18(13-16)23(24,25)26/h2,4-6,9,14-15,18H,3,7-8,10-13,16H2,1H3,(H,29,30,31,32,33);3-9,14-15H,10-13,16H2,1-2H3,(H,28,29,30,31,32);2-8,13-14,27H,9-12,15H2,1H3,(H,28,29,30,31,32);2-8,13-14H,9-12,15H2,1H3,(H,27,28,29,30,31);2,5-10,13-14H,3-4,11-12,15H2,1H3,(H,27,28,29,30,31)/b9-6+;5-3+,9-8+;2*4-2+,8-7+;6-2+,10-9+.
What are the key properties of N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine?
N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine has a molecular weight of 2305.49 g/mol, XLogP of 21.51, 25 rotatable bonds, 6 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-cyclopropyl-2H-pyrrol-5-yl)-4-(4-methyl-1,4-diazepan-1-yl)-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-(4-methylpiperazin-1-yl)-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-morpholin-4-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;4-piperazin-1-yl-N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine;N-[3-[(E)-prop-1-enyl]-2H-pyrrol-5-yl]-4-pyrrolidin-1-yl-6-[(E)-2-[3-(trifluoromethyl)phenyl]ethenyl]-1,3,5-triazin-2-amine is sourced from PubChem (CID 158755834), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).